Neonatal Disorder

SAN DIEGO — Paternal exposure to the majority of therapies for inflammatory bowel disease did not increase the risk for adverse neonatal outcomes, according to data from a small patient subset presented at Digestive Disease Week 2022.

Researchers observed no difference in functional neurodevelopment or epilepsy among children aged 24 months regardless of whether antiseizure medication was discontinued or maintained in infants at discharge once seizures ceased.

Prenatal cannabis use disorder was linked to increased risk for major adverse neonatal outcomes, according to results of a population-based, retrospective cohort study published in Addiction.

Women with eating disorders are at an increased risk for adverse pregnancy and neonatal outcomes and should thus be recognized as a high-risk population among pregnant women, according to results of a population-based cohort study published in JAMA Psychiatry.